There were many sessions today, but the one that captivated me and held me in my seat was on imaging. The session, organized by Carl Anderson (Duquesne University) and Steve Hammond (Pfizer), consisted of nine disparate talks tied together by the theme of imaging. Some of the highlights:
Raman spectroscopy, particularly hand-held Raman, is gaining favor as a pharmaceutical QC tool, given its convenience, speed and accuracy. A number of presentations at USP’s annual science meeting in Toronto discussed how hand-held Raman is being successfully used as part of pharmaceutical anticounterfeiting toolkits.
An fyi: Steve Simske of Hewlett-Packard offers a nice, unbiased (though HP-oriented) perspective on current anticounterfeiting measures from his Security Printing and Imaging blog. Definitely worth a view. Today he reminds us of the potential benefits of using stable isotopes as a way of authenticating processes by which APIs and...
One session on Wednesday morning addressed the use of molecular modeling in drug development. Ian Wilson, Portfolio and Strategy Manager, GE Healthcare discussed the development of PET clinical biomarkers. He mentioned the need to collaborate early, and the fact that academic partners can be great partners.